FDA Now Requiring GLP-1 Makers to Warn About Rare but Severe Eye Condition

FDA Now Requiring GLP-1 Makers to Warn About Rare but Severe Eye Condition

FDA orders new label warning for vision loss on GLP-1 drugs

FDA warns of rare vision-loss side effect from GLP-1 drugs

The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands.

FDA Adds Rare Vision-Loss Warning to Popular GLP-1 Drugs

The Food and Drug Administration is adding a warning about rare vision loss to popular GLP-1 drugs, the widely prescribed medications used for diabetes and weight loss. The Associated Press...